DEBIOC: A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophago-gastric adenocarcinoma

Thomas A., VIRDEE P., Martin E., LORD S., Falk S., Anthoney DA., Turkington R., GOFF M., ELHUSSEIN L., COLLINS L., Love S., MOSCHANDREAS J., MIDDLETON M.

DOI

10.1016/j.ejca.2019.10.010

Type

Journal article

Journal

European Journal of Cancer

Publisher

Elsevier

Publication Date

08/12/2019

Permalink Original publication